BioSpace News Archive

Drug Development

Lantern Pharma Announces Positive Preclinical Data in Glioblastoma (GBM) with Drug Candidate LP-184 and Expands GBM Research Collaboration

Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company, announced today that a successful preclinical study has shown its drug candidate LP-184 is able to inhibit tumor growth and improve survival in animal models of glioblastoma (GBM).

August 19, 2021
·
9 min read
Business

Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics

Daewoong Pharmaceutical and Hanall Biopharma of South Korea are expanding their global open collaboration initiative by investing in Alloplex Biotherapeutics, an emerging Boston-based biotechnology company.

August 19, 2021
·
2 min read
Business

Ultivue Announces New Independent Board Members

Ultivue announces the addition of two independent board members, Fenel Eloi and Mary Pat Lancelotta, to help strengthen its position as a leader in advancing precision medicine solutions by accelerating tissue biomarker discovery and validation.

August 19, 2021
·
2 min read
Deals

NRx Pharmaceuticals Announces $30 Million Private Placement

NRx Pharmaceuticals today announced that it has entered into definitive agreements with investors to purchase 2,727,273 shares of common stock in a private placement.

August 19, 2021
·
4 min read
Automated Visual Field Analyzer Market - Asian Pacific market is anticipated to show rapid growth compared to other regions | TMR Research Study

The ocular diseases are prevented and can be easily detected with the help of tools in the automated visual field.

August 19, 2021
·
4 min read
Business

Thomas Christély Joins Management of MetrioPharm AG as CEO

MetrioPharm AG, a pharmaceutical company developing drugs for chronic inflammatory diseases, is expanding its management team.

August 19, 2021
·
4 min read
Business

Becton, Dickinson and Company Announces Early Tender Results

Becton, Dickinson and Company announced the early tender results for its previously announced tender offers to purchase for cash any and all of the Company’s 2.894% senior notes due 2022 and 3.300% senior notes due 2023.

August 19, 2021
·
9 min read
Business

Stevanato Group Announces Second Quarter 2021 Financial Results

Stevanato Group S.p.A., a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced its financial results for the second quarter 2021 and established full-year 2021 guidance.

August 19, 2021
·
20 min read
Sterility Testing Market | Know the Diverse Growth Parameters Influencing the Market

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach.

August 19, 2021
·
6 min read
Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19

RELIEF THERAPEUTICS Holding SA reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals, Inc., provided a safety update on ZYESAMI which is being tested in the ACTIV-3 Critical Care Phase 3 study sponsored by the National Institutes of Health.

August 19, 2021
·
2 min read